Combination therapy with an angiotensin-converting-enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy - Nakamura, A; Shikata, K; Nakatou, T (J Diabetes Investig, 2013)
et al.